Tag: CSE:IPOT

May 14, 2020

Isracann Increases Focus on EU Demand

Company Targets Anticipated EU Undersupply and Growing Opportunity
May 8, 2020

Isracann JV in Israel Advances Towards Cannabis Production

Timeline to first planting now measured in weeks
April 8, 2020

Isracann Closes JV Cannabis Farm Production Agreement With 3-Year Offtake in Israel

Partnership puts timeline in place for earned revenues
March 24, 2020

Isracann Enters JV for Near-Term Cannabis Farm Production Opportunity in Israel

Isracann Biosciences (CSE:IPOT) is pleased to announce its entry into a joint venture agreement resulting in a phased partnership of...
February 27, 2020

Isracann Completes Executive Site and Prospect Visit in Israel

Management undertakes extensive review of action plan, vendor activities and tour of regional land opportunities
January 9, 2020

Isracann Receives Project Characterization Report and Engages EU GMP Consultancy

Extensive report details project infrastructure advantages, efficiencies and opportunities from inception to production
January 2, 2020

Isracann Enters MOU for European Distribution

Isracann Biosciences Inc. is pleased to announce entry into a Memorandum of Understanding towards a distribution agreement.